Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Market Cap	68.55B
Revenue (ttm)	6.17B +34.4%
Net Income	1.68B +26.3%
EPS	15.40 +25.4%
Shares Out	112.95M
PE Ratio	39.43
Forward PE	36.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	264,173
Average Volume	105,948
Open	623.80
Previous Close	627.35
Day's Range	593.75 - 644.90
52-Week Range	524.05 - 795.00
Beta	n/a
RSI	48.24
Earnings Date	Aug 19, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 740
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUDEEPPHRM

Financial Performance

In fiscal year 2025, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.